BridgeMD
New treatment option for Schizophrenia Disorders
Official title Cognitive Remediation Therapy for Schizophrenia: Effects on EEG and Emotional Regulation
ClinicalTrials.gov ID: NCT06936397
What this study is testing
- What it's testing
- This study aims to determine whether Cognitive Remediation Therapy (CRT) can improve attention, memory, and emotional regulation in people with schizophrenia. CRT is a structured program that includes exercises to strengthen cognitive skills such as problem-solving, working memory, and emotion regulation.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55. Healthy volunteers may be eligible.
You may be able to join if
- (Schizophrenia Group):
- Diagnosed with schizophrenia according to DSM-5 criteria
- Age between 18 and 55 years
- Clinically stable (no hospitalization or medication change within 1 month)
- Minimum primary school education
You likely can't join if
- (Both Groups):
- Current or past substance use disorder (within the past year)
- Comorbid neurological illness (e.g., epilepsy, traumatic brain injury)
- Current use of benzodiazepines or medications that significantly affect cognitive function
- Intellectual disability or MoCA score \< 20
- Visual or hearing impairments that could interfere with task performance
See the full eligibility criteria
- (Schizophrenia Group):
- Diagnosed with schizophrenia according to DSM-5 criteria
- Age between 18 and 55 years
- Clinically stable (no hospitalization or medication change within 1 month)
- Minimum primary school education
- Able to provide informed consent
- Right-handed (for EEG protocol consistency) (Healthy Control Group):
- No history of psychiatric or neurological disorders
- Age- and gender-matched to schizophrenia group
- No current medication affecting CNS
- Able to provide informed consent
- Right-handed
- (Both Groups):
- Current or past substance use disorder (within the past year)
- Comorbid neurological illness (e.g., epilepsy, traumatic brain injury)
- Current use of benzodiazepines or medications that significantly affect cognitive function
- Intellectual disability or MoCA score \< 20
- Visual or hearing impairments that could interfere with task performance
- Participation in a psychological intervention in the last 3 months
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.